Comparison of 2 Days Versus 5 Days of Octreotide After Endoscopic Therapy in Preventing Early Esophageal Varices Rebleed : A Randomized Controlled Study

• Status: Not yet recruiting
• Trial end date: 2023-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to compare the efficacy of 2-days versus 5-days octreotide infusion after endoscopic therapy in preventing early esophageal varices rebleed in patients with cirrhosis.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Tanta University
• Treatments: Octreotide

Criteria

Inclusion Criteria:

1. Acute esophageal varices bleeding

2. Liver cirrhosis

Exclusion Criteria:

1. Initial failure to control variceal bleed on endoscopy

2. Other causes of GIT bleeding

3. Hepatocellular carcinoma

4. Portal vein thrombosis

5. Renal dialysis and hepatorenal syndrome

6. History of myocardial infarction

7. Pregnancy or lactation

8. Allergy to octreotide